No Data
WIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion
Shandong Wit Dyne Health (000915.SZ): Subsidiary La Liga silicone oil emulsion obtained pharmaceutical registration certificate.
Gelonghui November 21st | Shandong Wit Dyne Health (000915.SZ) announced that recently, the company's subsidiary Shandong Dyne Marine Biopharmaceutical Co., Ltd. (referred to as Dyne Pharmaceuticals) has received the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration (Certificate No.: 2024S02791). The drug is named as Xijia Silicone Emulsion, indicated for: 1. Used to treat discomfort symptoms caused by excessive gas accumulation in the gastrointestinal tract: such as bloating, can also be used postoperatively. 2. Can be used as an adjuvant medication for abdominal imaging examinations (such as X-rays, ultrasound, gastroscopy) and for double contrast display.
There May Be Some Bright Spots In Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings
Walter Dyne: third quarter report 2024
Shandong Wit Dyne Health (000915.SZ): net income of 0.365 billion yuan in the first three quarters, a year-on-year decrease of 20.70%.
On October 25th, Gelonhui announced the third quarter report for 2024. The company achieved revenue of 1.378 billion yuan in the first three quarters, a year-on-year decrease of 19.83%; the net income attributable to shareholders of the listed company was 0.365 billion yuan, a year-on-year decrease of 20.70%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.345 billion yuan, a year-on-year decrease of 20.93%; and the basic earnings per share was 1.56 yuan.
Shandong WIT Dyne Health's Chief Financial Officer Resigns
We Think Shandong Wit Dyne HealthLtd's (SZSE:000915) Profit Is Only A Baseline For What They Can Achieve
No Data
